Skip to search formSkip to main contentSkip to account menu

efalizumab

Known as: anti alphaL integrin, antiCD11 alpha, efalizumab [Chemical/Ingredient] 
A humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Two cases of progressive multifocal leukoencephalopathy (PML) are reported in patients with psoriasis who were treated with… 
Highly Cited
2012
Highly Cited
2012
Objectives: Progressive multifocal leukoencephalopathy (PML) has become much more common with monoclonal antibody treatment for… 
Highly Cited
2012
Highly Cited
2012
Therapeutic monoclonal antibodies (mAbs) are currently being approved for marketing in Europe and the United States, as well as… 
Review
2010
Review
2010
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the white matter of the human brain caused by… 
Highly Cited
2003
Highly Cited
2003
A global picture of gene expression in the common immune-mediated skin disease, psoriasis, was obtained by interrogating the full… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND Leukocyte function-associated antigen 1 (LFA-1), consisting of CD11a and CD18 subunits, plays an important role in T… 
Highly Cited
1975
Highly Cited
1975
Methods for the cultivation of erythroid colonies in vitro are expected to allow selective assay of the earliest committed…